Drexel Neurosciences Institute Uses New FDA-Approved Epilepsy Treatment to Help Philadelphia …

Dr. Zakaria Hakma This is a significant advancement. The aim is to stop seizures before they occur. The surgery to implant the device is minimally invasive and the patient goes home the same day. Philadelphia, PA (PRWEB) September 28, 2015 A new epilepsy treatment recently approved by the FDA is helping a 20-year-old Philadelphia man and others in the area significantly reduce the number of seizures they experience. “I’ve gone as long as a week without a seizure. That’s never happened since I developed epilepsy,” said Christopher Davis, who lives in Northeast Philadelphia. He is among the first in the region to receive the implanted device to reduce seizures. Dr. Zakaria Hakma, a cerebrovascular/endovascular neurosurgeon with Drexel Neurosciences Institute (DNI), implanted the device, AspireSR, which can detect an on-coming seizure…


Link to Full Article: Drexel Neurosciences Institute Uses New FDA-Approved Epilepsy Treatment to Help Philadelphia …